p53 and Rb alterations in primary breast carcinoma: Correlation with hormone receptor expression and lymph node metastases

M. Drobnjak, Richard J Cote, A. D. Saad, T. Drudis, Z. Fuks, C. Cordon-Cardo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Expression of Rb and mutant p53 nuclear phosphoproteins was analyzed immunohistochemically in 69 breast cancer patients. Results were correlated with hormone receptor (ER and PR) and lymph node (LN) status. There was a significant association between the immunohistochemical evidence of p53 and/or Rb alterations and loss of hormone receptor expression. Mutations in p53 and/or low level Rb expression were not associated with the presence of axillary lymph node metastases. However, in patients with hormone receptor positive tumors, there was statistically significant correlation between altered expression of p53 and/or Rb and the presence of LN metastases. These results indicate that: (i) loss of steroid hormone receptor expression (and thus loss of hormonal growth control) is accompanied by somatic inactivation of the p53 or Rb tumor suppressor genes; and (ii) in tumors that remain under hormonal growth regulation inactivation of p53 and/or Rb may play a role in tumor progression.

Original languageEnglish
Pages (from-to)173-178
Number of pages6
JournalInternational Journal of Oncology
Volume2
Issue number2
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Lymph Nodes
Hormones
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Steroid Receptors
Phosphoproteins
Growth
Tumor Suppressor Genes
Mutation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

p53 and Rb alterations in primary breast carcinoma : Correlation with hormone receptor expression and lymph node metastases. / Drobnjak, M.; Cote, Richard J; Saad, A. D.; Drudis, T.; Fuks, Z.; Cordon-Cardo, C.

In: International Journal of Oncology, Vol. 2, No. 2, 01.01.1993, p. 173-178.

Research output: Contribution to journalArticle

@article{2bb9ebf8b31649bd9d1f7ac5b4d785cd,
title = "p53 and Rb alterations in primary breast carcinoma: Correlation with hormone receptor expression and lymph node metastases",
abstract = "Expression of Rb and mutant p53 nuclear phosphoproteins was analyzed immunohistochemically in 69 breast cancer patients. Results were correlated with hormone receptor (ER and PR) and lymph node (LN) status. There was a significant association between the immunohistochemical evidence of p53 and/or Rb alterations and loss of hormone receptor expression. Mutations in p53 and/or low level Rb expression were not associated with the presence of axillary lymph node metastases. However, in patients with hormone receptor positive tumors, there was statistically significant correlation between altered expression of p53 and/or Rb and the presence of LN metastases. These results indicate that: (i) loss of steroid hormone receptor expression (and thus loss of hormonal growth control) is accompanied by somatic inactivation of the p53 or Rb tumor suppressor genes; and (ii) in tumors that remain under hormonal growth regulation inactivation of p53 and/or Rb may play a role in tumor progression.",
author = "M. Drobnjak and Cote, {Richard J} and Saad, {A. D.} and T. Drudis and Z. Fuks and C. Cordon-Cardo",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "2",
pages = "173--178",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - p53 and Rb alterations in primary breast carcinoma

T2 - Correlation with hormone receptor expression and lymph node metastases

AU - Drobnjak, M.

AU - Cote, Richard J

AU - Saad, A. D.

AU - Drudis, T.

AU - Fuks, Z.

AU - Cordon-Cardo, C.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Expression of Rb and mutant p53 nuclear phosphoproteins was analyzed immunohistochemically in 69 breast cancer patients. Results were correlated with hormone receptor (ER and PR) and lymph node (LN) status. There was a significant association between the immunohistochemical evidence of p53 and/or Rb alterations and loss of hormone receptor expression. Mutations in p53 and/or low level Rb expression were not associated with the presence of axillary lymph node metastases. However, in patients with hormone receptor positive tumors, there was statistically significant correlation between altered expression of p53 and/or Rb and the presence of LN metastases. These results indicate that: (i) loss of steroid hormone receptor expression (and thus loss of hormonal growth control) is accompanied by somatic inactivation of the p53 or Rb tumor suppressor genes; and (ii) in tumors that remain under hormonal growth regulation inactivation of p53 and/or Rb may play a role in tumor progression.

AB - Expression of Rb and mutant p53 nuclear phosphoproteins was analyzed immunohistochemically in 69 breast cancer patients. Results were correlated with hormone receptor (ER and PR) and lymph node (LN) status. There was a significant association between the immunohistochemical evidence of p53 and/or Rb alterations and loss of hormone receptor expression. Mutations in p53 and/or low level Rb expression were not associated with the presence of axillary lymph node metastases. However, in patients with hormone receptor positive tumors, there was statistically significant correlation between altered expression of p53 and/or Rb and the presence of LN metastases. These results indicate that: (i) loss of steroid hormone receptor expression (and thus loss of hormonal growth control) is accompanied by somatic inactivation of the p53 or Rb tumor suppressor genes; and (ii) in tumors that remain under hormonal growth regulation inactivation of p53 and/or Rb may play a role in tumor progression.

UR - http://www.scopus.com/inward/record.url?scp=0027458745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027458745&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027458745

VL - 2

SP - 173

EP - 178

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -